Skip to content
#
Title
1

Ketamine for Sickle Cell Disease

2

Tirzepatide for Sleep Apnea

3

Excoriation Disorder

4

Phenytoin for Tacrolimus Toxicity

5

Atypical Antipsychotics and QT–prolongation

6

Apixaban in Peripheral Artery Disease

7

Safety and Efficacy of RSV Vaccines

8

Safety and Efficacy of Rezafungin

9

Perioperative Duloxetine During Orthopedic Surgery for Pain Reduction

10

Lecanemab in the treatment of Alzheimer's Dementia

11

Tirzepatide for Weight Loss in Diabetic Patients

12

Yet Another Drug Shortage? Alternatives to Oxytocin

13

Can Evusheld Increase Cardiovascular Events?

14

Could Intermittent Fasting be the Next Big Weight Loss Tool?

15

A 4th Dose of the COVID-19 Vaccine

16

A Possible Alternative for Recurrent Urinary Tract Infections

17

Estimation of Breast Cancer Overdiagnosis

18

Can Ketamine Treat Acute, Severe Suicidal Ideation?

19

Could SER-109 be an Answer for Recurrent C.Difficile Infection?

20

To Boost or not to Boost - That is the Question

21

Old Dogs Can Learn New Tricks: Is Outpatient Remdesivir a Game Changer against Omicron?

22

Can Financial Incentives Help Pregnant Patients Quit Smoking?

23

Milvexian for the Prevention of Venous Thromboembolism

24

Merck's New COVID-19 Pill - Molnupiravir

25

Can chlorthalidone therapy improve blood-pressure control in patients with advanced CKD?

26

Does the Addition of Vasopressin and Methylprednisolone Improve Outcomes in Patients with In-Hospital Cardiac Arrest?

27

Can fluvoxamine prevent COVID-19 related hospitalization?

28

Can MDMA Treat Post-Traumatic Stress Disorder?

29

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

30

Functional Neurological Disorder after COVID-19 Vaccination

31

Myocarditis after COVID-19 Vaccination

32

World Trade Center Dust Exposure and Hepatic Steatosis

33

Processed Foods and the Risk of Inflammatory Bowel Disease

34

Childhood Trauma and Rewarding Effects of Morphine

35

Can a Cup of Coffee Keep the Cardiologist Away?

36

An Intra-Oral Device for Weight Loss

37

Curious Cases of Mucormycosis

38

Continuous Glucose Monitoring in Patients With Type-2 Diabetes Receiving Basal Insulin

39

Once-Weekly Semaglutide in Adults with Overweight or Obesity

40

Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients With Traumatic Brain Injury

41

Sacituzumab Govitecan (Trodelvy) in Metastatic Triple-Negative Breast Cancer

42

Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis

43

The MIDAS Trial: Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit

44

Post-Covid Syndrome and Rates of Organ Dysfunction

45

Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation for COVID-19 Patients

46

Acute Kidney Injury in COVID-19 Patients After Hospital Discharge

47

Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Patients with COVID-19

48

Dexamethasone in Hospitalized Patients with COVID-19

49

Vitamin-D3 Supplementation and COVID-19

50

Effect of Zinc and Vitamin-C on Ambulatory Patients with COVID-19

51

Anaphylaxis after Pfizer Vaccine

52

Association of Psychiatric Disorders and COVID-19

53

Preliminary Data on Johnson and Johnson Vaccine

54

Clinical Characteristics of COVID-19 in Hematopoietic Stem-Cell Transplantation Recipients

55

Continuation versus discontinuation of RAAS inhibitors in hospitalized patients with COVID-19

56

Comparative Differences Between COVID-19 and Seasonal Influenza

57

Efficacy and Safety of the Moderna mRNA-1273 SARS-CoV-2 Vaccine to Prevent COVID-19

58

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19 (ACTT-2)

59

Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic

60

Simultaneous COVID-19 in Homozygous Twins

61

Adjusted BMI and risk of death due to COVID-19

62

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomized, double-blind, placebo-controlled, phase 2 trial

63

Bamlanivimab - SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

64

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

65

Levels of Severity of Depressive Symptoms Among At-Risk Groups During COVID-19

66

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

67

Genomic evidence for reinfection with SARS-CoV-2: a case study

68

Remdesivir for the Treatment of Covid-19 — Final Report

69

Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of COVID-19 in SARS-CoV-2 infected male patients: a cohort study

70

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

71

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among US Veterans With SARS-CoV-2 Infection

72

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

73

Cell Phone Activity in Categories of Places and Associations With Growth in Cases of COVID-19 in the US

74

Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19

75

Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial

76

Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals

77

The Effects of Progressive Muscle Relaxation on Sleep Quality and Anxiety in COVID-19 Patients

78

Is there evidence on the use of lopinavir–ritonavir compared to standard care in hospitalized patients with Corona Virus Disease (COVID-19)?